Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs

Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were developed in record time and show excellent efficacy and effectiveness against coronavirus disease 2019 (COVID-19). However, currently approved vaccines cannot meet the global demand. In addition, none of the currentl...

Descripción completa

Detalles Bibliográficos
Autores principales: Lara-Puente, Jesús Horacio, Carreño, Juan Manuel, Sun, Weina, Suárez-Martínez, Alejandro, Ramírez-Martínez, Luis, Quezada-Monroy, Francisco, Paz-De la Rosa, Georgina, Vigueras-Moreno, Rosalía, Singh, Gagandeep, Rojas-Martínez, Oscar, Chagoya-Cortés, Héctor Elías, Sarfati-Mizrahi, David, Soto-Priante, Ernesto, López-Macías, Constantino, Krammer, Florian, Castro-Peralta, Felipa, Palese, Peter, García-Sastre, Adolfo, Lozano-Dubernard, Bernardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546847/
https://www.ncbi.nlm.nih.gov/pubmed/34544278
http://dx.doi.org/10.1128/mBio.01908-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546847/
https://www.ncbi.nlm.nih.gov/pubmed/34544278
http://dx.doi.org/10.1128/mBio.01908-21

Ejemplares similares